Cheyanne Williamson, PA
Medical · Manhattan, KSNPI 1487176236
Payments from drug & device makers
Across 82 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$235
- Pfizer$200
- Lilly USA, LLC$175
- AstraZeneca$137
- Novo Nordisk$96
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
- plus $501 from 15 others
What the payments were for
- Food & beverage$1,425100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $235 |
| Pfizer | 13 | $200 |
| Lilly USA, LLC | 9 | $175 |
| AstraZeneca | 8 | $137 |
| Novo Nordisk | 6 | $96 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $81 |
| Abbott | 2 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| GSK | 4 | $61 |
| Corcept Therapeutics | 3 | $46 |
| Acadia Pharmaceuticals Inc | 2 | $37 |
| CSL Behring | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Boehringer Ingelheim | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Biogen | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
How this compares
$1,425 in reported general payments places this provider in the 60th percentile of 205 medical providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 12 | $25,406 |
| JardianceEmpagliflozin | 30 | $25,082 |
| OzempicSemaglutide | 26 | $23,814 |
| EliquisApixaban | 13 | $7,540 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 16 | $3,386 |
| Levetiracetam | 22 | $2,101 |
| Tolterodine Tartrate ErTolterodine Tartrate | 12 | $1,823 |
| HumalogInsulin Lispro | 13 | $1,778 |
| Fentanyl | 19 | $1,706 |
| Memantine Hcl | 56 | $1,628 |
| Mirtazapine | 70 | $1,522 |
| PaxlovidNirmatrelvir/Ritonavir | 17 | $1,429 |
| Levothyroxine Sodium | 120 | $1,255 |
| Rosuvastatin Calcium | 59 | $1,116 |
| Divalproex Sodium | 30 | $729 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $96 | $49,22138 claims |
| Boehringer IngelheimJardiance | $29 | $25,08230 claims |
| PfizerEliquis, Paxlovid | $200 | $8,96930 claims |
| GSKShingrix | $61 | $3,38616 claims |
| Lilly USA, LLCHumalog | $175 | $1,77813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 205 medical providers in Kansas.
Other medical in Manhattan
- Kerri MaxcyManhattan$6K
- Larry PierceManhattan$3K
- Linly StevensOverland Park$111K
- Shana ArnholdShawnee$82K
- Richard AllenbachWichita$70K
- Laura LudlowTopeka$61K
- Anita KishOlathe$58K
- Kathryn WelchWichita$32K
- Courtney SteneOverland Park$22K
- Janella DewittOverland Park$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.